Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metraplant-E vs Yasmin in Adenomyosis
NCT03037944Phase 1Unknown
- Sponsor
- Ain Shams University Maternity Hospital
- Start
- Mar 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of avatrombopag in adenomyosis (2 arms), sponsored by Ain Shams University Maternity Hospital. Primary endpoints: Measurement of pain by pain measurement score at 6 months and Number of bleeding days at 6 months. Status: unknown.
02
Drugs
avatrombopag
03
Conditions
adenomyosis
Beyond the preview
Go deeper on NCT03037944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03037944.